Literature DB >> 24000297

Prospective risk factor monitoring reduces intracranial hemorrhage rates in preterm infants.

Manuel B Schmid1, Frank Reister, Benjamin Mayer, Reinhard J Hopfner, Hans Fuchs, Helmut D Hummler.   

Abstract

BACKGROUND: Intracranial hemorrhage occurs in 20% to 25% of neonates born before the 30th week of gestation or weighing less than 1500 grams at birth. These hemorrhages carry a risk of long-term neurocognitive damage. Measures for lowering the incidence of intracranial hemorrhage were evaluated.
METHODS: A working group at the University of Ulm, Germany, developed a prospective monitoring program for risk factors and a bundle of measures including altered clinical approaches to delivery, initial care of the neonate in the delivery room immediately after birth, and intensive care in the first few days thereafter. Adherence to these measures was checked once per week. The evaluation was performed prospectively for a period of 23 months (August 2010 to July 2012) with a 31-month period of historical controls (January 2008 to July 2010).
RESULTS: In the reference period before the intervention was introduced, 263 neonates weighing less than 1500 grams and with a median (quartile) gestational age at birth of 27.4 (25.4-29.9) weeks were treated. The incidence of intracranial hemorrhage was 22.1%, and that of high-grade hemorrhage was 9.1%. The mortality was 6.1%, and the rate of survival without brain hemorrhage was 74.5%. After the bundle of preventive measures was introduced, 191 neonates weighing less than 1500 grams and with a median (quartile) gestational age at birth of 28.0 (26.0, 30.3) weeks were treated. The incidence of intracranial hemorrhage dropped to 10.5% (odds ratio [OR] 0.43, 95% confidence interval [CI] 0.25-0.73); the incidence of high-grade hemorrhage dropped to 3.7% (OR 0.36; 95% CI 0.14-0.89). The mortality was no different at 6.3%, and 85.3% of the children survived without a hemorrhage (OR 1.95, 95% CI 1.20-3.15). After statistical adjustment for higher gestational age, the OR for intracranial hemorrhage (IVH) was 0.49 (0.28-0.86) and the probability of survival without IVH improved (OR 1.68, 95% CI 1.01-2.81).
CONCLUSION: The rate of brain hemorrhage in premature neonates can be considerably lowered by prospective monitoring of risk factors.

Entities:  

Mesh:

Year:  2013        PMID: 24000297      PMCID: PMC3752580          DOI: 10.3238/arztebl.2013.0489

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  35 in total

1.  Variations in intraventricular hemorrhage incidence rates among Canadian neonatal intensive care units.

Authors:  A R Synnes; L Y Chien; A Peliowski; R Baboolal; S K Lee
Journal:  J Pediatr       Date:  2001-04       Impact factor: 4.406

2.  Effectiveness of a rescue dose of antenatal betamethasone after an initial single course.

Authors:  S T Vermillion; M L Bland; D E Soper
Journal:  Am J Obstet Gynecol       Date:  2001-11       Impact factor: 8.661

3.  Implementation of potentially better practices for the prevention of brain hemorrhage and ischemic brain injury in very low birth weight infants.

Authors:  Debra McLendon; Jennifer Check; Patricia Carteaux; Laura Michael; Jim Moehring; Joel W Secrest; Sue E Clark; Howard Cohen; Sharon A Klein; Diane Boyle; Jeffrey A George; Susan Okuno-Jones; Debora S Buchanan; Pam McKinley; Jonathan M Whitfield
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

4.  Evaluation and development of potentially better practices for the prevention of brain hemorrhage and ischemic brain injury in very low birth weight infants.

Authors:  Patricia Carteaux; Howard Cohen; Jennifer Check; Jeffrey George; Pamela McKinley; William Lewis; Patricia Hegwood; Jonathan M Whitfield; Debra McLendon; Susan Okuno-Jones; Sharon Klein; Jim Moehring; Connie McConnell
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

5.  Low superior vena cava flow and intraventricular haemorrhage in preterm infants.

Authors:  M Kluckow; N Evans
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

6.  Sustained improvement? Findings from an independent case study of the Jönköping quality program.

Authors:  John Øvretveit; Anthony Staines
Journal:  Qual Manag Health Care       Date:  2007 Jan-Mar       Impact factor: 0.926

7.  Risk-adjusted intraventricular hemorrhage rates in very premature infants: towards quality assurance between neonatal units.

Authors:  Christoph Vogtmann; Rainer Koch; Dieter Gmyrek; Annette Kaiser; Annette Friedrich
Journal:  Dtsch Arztebl Int       Date:  2012-08-06       Impact factor: 5.594

8.  Trends in mortality and morbidity for very low birth weight infants, 1991-1999.

Authors:  Jeffrey D Horbar; Gary J Badger; Joseph H Carpenter; Avroy A Fanaroff; Sarah Kilpatrick; Meena LaCorte; Roderic Phibbs; Roger F Soll
Journal:  Pediatrics       Date:  2002-07       Impact factor: 7.124

9.  Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-01-30       Impact factor: 17.586

10.  Comparing regional infant death rates: the influence of preterm births <24 weeks of gestation.

Authors:  Lucy Smith; Elizabeth S Draper; Bradley N Manktelow; Catherine Pritchard; David John Field
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2012-06-09       Impact factor: 5.747

View more
  14 in total

1.  Prevention at the beginning of life: cerebral hemorrhage in very preterm infants.

Authors:  Harald Ehrhardt; Klaus-Peter Zimmer
Journal:  Dtsch Arztebl Int       Date:  2013-07       Impact factor: 5.594

2.  Singapore Neonatal Resuscitation Guidelines 2016.

Authors:  Cheo Lian Yeo; Agnihotri Biswas; Teong Tai Kenny Ee; Amutha Chinnadurai; Vijayendra Ranjan Baral; Alvin Shang Ming Chang; Imelda Lustestica Ereno; Kah Ying Selina Ho; Woei Bing Poon; Varsha Atul Shah; Bin Huey Quek
Journal:  Singapore Med J       Date:  2017-07       Impact factor: 1.858

3.  In reply.

Authors:  Manuel B Schmid
Journal:  Dtsch Arztebl Int       Date:  2014-01-24       Impact factor: 5.594

4.  Consider using heparin.

Authors:  Holger Kiesewetter
Journal:  Dtsch Arztebl Int       Date:  2014-01-24       Impact factor: 5.594

Review 5.  Predicting clinical outcomes using artificial intelligence and machine learning in neonatal intensive care units: a systematic review.

Authors:  Ryan M McAdams; Ravneet Kaur; Yao Sun; Harlieen Bindra; Su Jin Cho; Harpreet Singh
Journal:  J Perinatol       Date:  2022-05-13       Impact factor: 2.521

6.  Extremely low gestational age infants: Developing a multidisciplinary care bundle.

Authors:  Emanuela Ferretti; Thierry Daboval; Nicole Rouvinez-Bouali; Sarah L Lawrence; Brigitte Lemyre
Journal:  Paediatr Child Health       Date:  2020-11-17       Impact factor: 2.253

7.  Neuroprotection care bundle implementation is associated with improved long-term neurodevelopmental outcomes in extremely premature infants.

Authors:  Amina Benlamri; Prashanth Murthy; Hussein Zein; Sumesh Thomas; James N Scott; Ayman Abou Mehrem; Michael J Esser; Abhay Lodha; Jennessa Noort; Selphee Tang; Cathy Metcalfe; Derek Kowal; Leigh Irvine; Jillian Scotland; Lara M Leijser; Khorshid Mohammad
Journal:  J Perinatol       Date:  2022-07-13       Impact factor: 3.225

8.  Prevention of severe brain injury in very preterm neonates: A quality improvement initiative.

Authors:  Vivek V Shukla; Andrew Klinger; Siamak Yazdi; A K M Fazlur Rahman; Sydney Wright; Angela Barganier; Namasivayam Ambalavanan; Waldemar A Carlo; Manimaran Ramani
Journal:  J Perinatol       Date:  2022-07-01       Impact factor: 3.225

Review 9.  Advancements in neonatology through quality improvement.

Authors:  Stephen A Pearlman
Journal:  J Perinatol       Date:  2022-04-02       Impact factor: 3.225

Review 10.  Precision Medicine in Neonates: A Tailored Approach to Neonatal Brain Injury.

Authors:  Maria Luisa Tataranno; Daniel C Vijlbrief; Jeroen Dudink; Manon J N L Benders
Journal:  Front Pediatr       Date:  2021-05-19       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.